Internal Trainer
About the job
- A minimum Bac+2 scientific or technical education is required.
- Successful experience in pharmaceutical production or as a trainer in an industrial environment is required; pharmaceutical, cosmetics, or food-processing experience is preferred.
- Interest in new technologies and new training methods is required.
- The role requires adaptability, autonomy, rigor, initiative, organization, and the ability to process a large volume of documents.
- Define and maintain the training-module map, including available modules and validated trainers.
- Analyze needs and design and develop training modules in close collaboration with clients.
- Monitor new teaching methods.
- Ensure compliance with the training process at the assigned sites.
- Maintain training records properly.
- Open deviation records and conduct impact assessments.
- Follow up on Quality action plans.
- Write and approve operating procedures.
- Act as the document reference for the assigned scope.
- Participate in cross-functional projects as a Training team member.
- Experience in pharmaceutical, cosmetics, or food-processing environments is preferred.
About the company
LFB is a French biopharmaceutical company that develops and manufactures medicines from plasma and biotech products. It collects plasma, fractionates it into medicines, and also produces recombinant proteins for rare diseases in immunology and hemostasis, sold in many countries. It stands out because it started as a state-initiated public health mission and remains state-owned with the French State as sole shareholder, plus vertical integration through acquisitions of plasma collection firms. Its goal is to ensure a reliable supply of essential medicines for public health while growing as a global biopharma player.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Courcebœufs, France
Founded
1994
Get referred to LFB
See people who can refer or advise you
Simplify's Take
What believers are saying
- Arras released first medicines in 2025, proving commercialization after heavy capital spending.
- LFB signed a 2026 collaboration with Sartorius to accelerate client programs and GMP manufacturing.
- France 2030 funding and the 2026 Alès expansion add capacity and roughly fifty jobs.
What critics are saying
- EFS must raise plasma collections to 1.4 million liters by 2028 or Arras underutilizes.
- LFB BIOMANUFACTURING still depends on Sartorius for cell line development, limiting full-stack control.
- A single French industrial base creates existential exposure to contamination, recalls, or regulatory shutdowns.
What makes LFB unique
- French state-owned sole domestic plasma fractionator anchors national medicine supply.
- Arras plant, authorized in 2025, centralizes production and triples plasma-derived capacity.
- Europlasma and Amber Plasma give LFB 24 Central European collection centers.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- 401(k) Retirement Plan
- Remote Work Options
- Unlimited Paid Time Off
- Flexible Work Hours
- Paid Vacation
- Hybrid Work Options
- Wellness Program
- Mental Health Support
- Phone/Internet Stipend
- Home Office Stipend
- Stock Options